Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Genetic Landscape of BPDCN Arising in CML Remission

Masataka Takeshita, Nobuyuki Kodama, Tomoko Hishima, Koji Okazaki, Akira Tanimura, Risen Hirai, Naomi Abe, Daisuke Kudo, Seishi Ogawa, Yasuhito Nannya, Akiyoshi Miwa

Blood (2022) 140 (Supplement 1): 11801–11803.

https://doi.org/10.1182/blood-2022-168948

Published: 2022

Journal Articles

Impact of Combining Frailty Assessment Systems to Select Elderly Myeloma Patients Eligible for Autologous Peripheral Blood Stem Cell Transplantation

Akira Tanimura, Koji Okazaki, MD, Yuko Okuda, MD, Risen Hirai, MD, Daisuke Kudo, MD, Masataka Takeshita, MD PhD, Akiyoshi Miwa, MD, PhD

Blood (2019) 134 (Supplement_1): 5706.

https://doi.org/10.1182/blood-2019-122084

Published: 2019

Journal Articles

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

Masataka Takeshita, MD PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD PhD, Shotaro Hagiwara, MD PhD, Akiyoshi Miwa, MD PhD

Blood (2014) 124 (21): 5837.

https://doi.org/10.1182/blood.V124.21.5837.5837

Published: 2014

Journal Articles

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

Sohtaro Mine, MD, Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD, Toru Igari, MD PhD

Blood (2013) 122 (21): 5321.

https://doi.org/10.1182/blood.V122.21.5321.5321

Published: 2013

Journal Articles

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD

Blood (2013) 122 (21): 2171.

https://doi.org/10.1182/blood.V122.21.2171.2171

Published: 2013

Journal Articles

What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -

Akira Tanimura, MD, Risen Hirai, MD, Atsushi Sato, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Shotaro Hagiwara, MD, PhD, Akiyoshi Miwa, MD

Blood (2012) 120 (21): 3639.

https://doi.org/10.1182/blood.V120.21.3639.3639

Published: 2012

Journal Articles

High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan

Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Atsushi Sato, MD, Junichiro Takano, MD, Hideaki Kitahara, MD, Ayato Tsukamoto, MD, Yuko Kimura, MD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Shotaro Hagiwara, MD, PhD, Mineo Kurokawa, MD, PhD, Akiyoshi Miwa, MD

Blood (2011) 118 (21): 2007.

https://doi.org/10.1182/blood.V118.21.2007.2007

Published: 2011

Journal Articles

Direct Myeloma Cell Invasion as One of the Major Causes of Renal Impairment In Myeloma A Pathological Analysis of Renal Findings In 41 Autopsied Cases

Amane Tagashira, MD., Junichiro Takano, MD., Shotaro Hagiwara, MD., PhD., Makoto Mochizuki, MD., PhD., Hisako Endo, MD., PhD., Risen Hirai, MD., Akira Tanimura, MD., Masataka Takeshita, MD., PhD., Hirokazu Murakami, MD, PhD, Akiyoshi Miwa, MD.

Blood (2010) 116 (21): 5001.

https://doi.org/10.1182/blood.V116.21.5001.5001

Published: 2010

Journal Articles

Multi-Organ Involvement of Multiple Myeloma Cells In the Cases of Recent 10 Years: A Clinicopathologic Study of 81 Consecutively Autopsied Cases

Shotaro Hagiwara, MD., PhD., Makoto Mochizuki, MD., PhD., Hisako Endo, MD., PhD., Risen Hirai, MD., Akira Tanimura, MD., Masataka Takeshita, MD., PhD., Hirokazu Murakami, MD, PhD, Akiyoshi Miwa, MD.

Blood (2010) 116 (21): 5004.

https://doi.org/10.1182/blood.V116.21.5004.5004

Published: 2010

Journal Articles

Implication of AML1/RUNX1 Function in the Homeostasis and Leukemic Transformation of Hematopoietic Stem Cells.

Motoshi Ichikawa, MD, PhD, Masataka Takeshita, MD,PhD, Susumu Goyama, MD,PhD, Takashi Asai, MD,PhD, Eriko Nitta, MD,PhD, Masahiro Nakagawa, MD,PhD, Masahito Kawazu, MD,PhD, Shigeru Chiba, MD,PhD, Seishi Ogawa, MD,PhD, Mineo Kurokawa, MD,PhD

Blood (2007) 110 (11): 4117.

https://doi.org/10.1182/blood.V110.11.4117.4117

Published: 2007

Journal Articles

AML1/Runx1 Negatively Regulates the Number of Quiescent Hematopoietic Stem Cells in Adult Hematopoiesis.

Motoshi Ichikawa, MD, PhD, Takashi Asai, MD, PhD, Masahiro Nakagawa, MD, PhD, Masahito Kawazu, MD, PhD, Susumu Goyama, MD, PhD, Masataka Takeshita, MD, Shigeru Chiba, MD, PhD, Seishi Ogawa, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2006) 108 (11): 4204.

https://doi.org/10.1182/blood.V108.11.4204.4204

Published: 2006

Journal Articles

Cas-L Suppresses Progression of Leukemia Induced by p210 Bcr/Abl .

Sachiko Seo, MD, Tetsuya Nakamoto, M.D., Takahiro Suzuki, M.D., Masataka Takeshita, M.D., Motoshi Ichikawa, M.D., Shigeru Chiba, M.D., Seishi Ogawa, M.D., Hiroaki Honda, M.D., Hideaki Oda, M.D., Mineo Kurokawa, M.D.

Blood (2006) 108 (11): 4816.

https://doi.org/10.1182/blood.V108.11.4816.4816

Published: 2006

Journal Articles

Ki23819 (KRN383•HCl) Inhibits Kinase Activity of Wild Type and Mutant FLT3 Receptor Tyrosine Kinase In Vitro .

Yukiko Komeno, Mineo Kurokawa, Yoichi Imai, Masataka Takeshita, Tomoko Matsumura, Kazuo Kubo, Tetsuya Yoshino, Uichi Nishiyama, Tomoaki Kuwaki, Kinya Kubo, Tatsushi Osawa, Seishi Ogawa, Shigeru Chiba, Atsushi Miwa, Hisamaru Hirai

Blood (2004) 104 (11): 1168.

https://doi.org/10.1182/blood.V104.11.1168.1168

Published: 2004

NARROW

Genetic Landscape of BPDCN Arising in CML Remission

Impact of Combining Frailty Assessment Systems to Select Elderly Myeloma Patients Eligible for Autologous Peripheral Blood Stem Cell Transplantation

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -

High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan

Direct Myeloma Cell Invasion as One of the Major Causes of Renal Impairment In Myeloma A Pathological Analysis of Renal Findings In 41 Autopsied Cases

Multi-Organ Involvement of Multiple Myeloma Cells In the Cases of Recent 10 Years: A Clinicopathologic Study of 81 Consecutively Autopsied Cases

Implication of AML1/RUNX1 Function in the Homeostasis and Leukemic Transformation of Hematopoietic Stem Cells.

AML1/Runx1 Negatively Regulates the Number of Quiescent Hematopoietic Stem Cells in Adult Hematopoiesis.

Cas-L Suppresses Progression of Leukemia Induced by p210 Bcr/Abl .

Ki23819 (KRN383•HCl) Inhibits Kinase Activity of Wild Type and Mutant FLT3 Receptor Tyrosine Kinase In Vitro .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only